Search clinical trials for: rectal cancer short-course chemoradiotherapy

Total 87744 results

National Cancer Institute (NCI)

Completed

The Collection of Peripheral Blood Lymphocytes and Marrow Progenitor Cells From Normal Volunteers and Volunteers With Lymphoid or Hematologic Malignancies

Lymphoma | Healthy | Chronic Myeloid Leukemia | Hematologic Neoplasm

United States
National Cancer Institute (NCI)

Completed

Phase I Study to Evaluate the Safety and Immunogenicity of HIV-1 Immunogen in Children With HIV-1 Infection

HIV Infection

United States
National Cancer Institute (NCI)

Completed

Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits

Acquired Immunodeficiency Syndrome | Smoking | Alcoholism | HIV Infection | Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer

Kidney Neoplasms | Neoplasm Metastasis

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver

Neoplasm Metastasis | Liver Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Pilot Trial of Topical Thalidomide for the Management of Chronic Discoid Lupus Erythematosus

Discoid Lupus Erythematosus

United States
National Cancer Institute (NCI)

Completed

Vinorelbine and XR9576 to Treat Cancer

Cancer | Breast Cancer | Ovarian Cancer | Lung Cancer

United States
National Cancer Institute (NCI)

Completed

Correlation of HIV Levels With Clinical and Immunologic Outcome in Children Treated With Didanosine

HIV Infection

United States
National Cancer Institute (NCI)

Completed

Effects of Raloxifene on Hormone Levels

Breast Cancer

United States
National Cancer Institute (NCI)

Completed

The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection

HIV Infections | Speech Disorders | Candidiasis, Oral | Eating Disorders

United States
National Institute of Neurological Disorders and...

Completed

Analysis of Brain Metastasis in Patients With Breast Cancer, With and Without Over-Expression of HER-2

Breast Neoplasms

United States
National Heart, Lung, and Blood Institute (NHLBI)

Completed

A Randomized Trial of Recombinant Humanized Anti-IL-2 Receptor Antibody (Daclizumab) Versus Antithymocyte Globulin (ATG) to Treat the Cytopenia of Myelodysplastic Syndrome (MDS)

Myelodysplastic Syndromes

United States
National Cancer Institute (NCI)

Completed

The Role of Multi-Modality Therapy for the Treatment of High-Grade Soft Tissue Sarcomas of the Extremities

Sarcoma

United States
National Cancer Institute (NCI)

Completed

A Randomized Phase III Trial of Hyperthermic Isolated Limb Perfusion With Melphalan, Tumor Necrosis Factor, and Interferon-Gamma in Patients With Locally Advanced Extremity Melanoma

Melanoma

United States
National Cancer Institute (NCI)

Completed

A Trial of Carboxypeptidase-G2 (CPDG2) and Thymidine for the Management of Patients With Methotrexate Toxicity and Renal Dysfunction

Kidney Diseases

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Infusional Paclitaxel With the P-Glycoprotein Antagonist PSC 833

Lymphoma | Carcinoma, Renal Cell | Cancer | Breast Cancer | Ovarian Cancer

United States
National Cancer Institute (NCI)

Completed

Phase I and Pharmacokinetic Trial of Paclitaxel (Taxol) Given as a 3-Hour Infusion in Pediatric Patients With Refractory Malignancy

Neoplasms

United States
National Cancer Institute (NCI)

Completed

Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis

Psoriasis

United States
National Cancer Institute (NCI)

Completed

Immunization of HLA-A201 Patients With Metastatic Melanoma Using a Combination of Immunodominant Peptides From Three Melanoma Antigens, MART-1, GP100 and Tyrosinase

Melanoma | Neoplasm Metastasis

United States
National Institutes of Health Clinical Center (CC)

Completed

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Nasopharyngeal Neoplasms

United States
National Cancer Institute (NCI)

Completed

SU5416 and Carboplatin to Treat Ovarian Cancer

Ovarian Cancer | Peritoneal Neoplasm | Fallopian Tube Neoplasm

United States
National Human Genome Research Institute (NHGRI)

Completed

Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods

Prostate Cancer

United States
National Cancer Institute (NCI)

Completed

Evaluation and Natural History of Children With Cancer and AIDS

HIV Infections | Acquired Immunodeficiency Syndrome | Lymphoma | Leukemia | Cancer

United States
National Cancer Institute (NCI)

Completed

A Phase I Trial Using Suramin to Treat Superficial Transitional Cell Carcinoma of the Bladder

Carcinoma, Transitional Cell | Bladder Neoplasms

United States
National Cancer Institute (NCI)

Completed

The Impact of Starbright World on Children Being Treated at the NIH

Child, Hospitalized

United States
National Cancer Institute (NCI)

Completed

Induction of Suction Blisters in Patients With Urticaria, Blistering Diseases, Inflammatory Dermatoses and Neoplastic Disorders, and in Normal Volunteers

Healthy | Dermatitis | Neoplasm | Urticaria | Vesiculobullous Skin Disease

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of Infusional Chemotherapy With the P-Glycoprotein Antagonist PSC 833

Lymphoma | Breast Cancer | Neoplasm Metastasis | Ovarian Cancer | Kidney Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes

HIV Infections | Immunologic Deficiency Syndromes | Lymphoproliferative Disorders

United States
National Cancer Institute (NCI)

Completed

A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancer

Prostatic Neoplasm

United States
National Cancer Institute (NCI)

Completed

Oxaliplatin to Treat Advanced Cancers With Liver Dysfunction

Liver Disease

United States
National Cancer Institute (NCI)

Completed

A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia

Hairy Cell Leukemia

United States
National Cancer Institute (NCI)

Completed

A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients

Breast Cancer | Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma

Neoplasm Metastasis | Osteosarcoma

United States
National Cancer Institute (NCI)

Completed

Phase I and Pharmacokinetic Trial of Phenylbutyrate Given as a Continuous Infusion in Pediatric Patients With Refractory Malignancy

Brain Neoplasms | Neuroblastoma

United States
National Cancer Institute (NCI)

Completed

Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria

Cancer | Neoplasm Metastasis | Neoplasm

United States
National Cancer Institute (NCI)

Completed

Tissue Acquisition for Molecular Diagnostics

Neoplasm

United States
National Cancer Institute (NCI)

Completed

A Phase II Evaluation of Telesurgery Systems

Laparoscopy

United States
National Cancer Institute (NCI)

Completed

Comparing the Effectiveness of Fluconazole and a New Medicine (FK463) in Preventing Fungal Infections in Bone Marrow Transplant Patients

Mycoses | Candidiasis | Fungemia | Aspergillosis

United States
National Institute of Diabetes and Digestive and...

Completed

The Effect of Thyroid Hormone on Drug Elimination in Cancer Patients

Thyroid Cancer

United States
National Human Genome Research Institute (NHGRI)

Completed

Outcomes of Education and Counseling for BRCA1 Testing

Breast Neoplasms | Ovarian Neoplasms

United States
National Cancer Institute (NCI)

Completed

Research in Skin Inflammation

Psoriasis

United States
National Cancer Institute (NCI)

Completed

A Pilot Trial of Tamoxifen and 4-HPR (4-N-Hydroxyphenyl Retinamide) in Persons at High Risk for Developing Breast Cancer

Breast Cancer | Breast Neoplasms

United States
National Cancer Institute (NCI)

Completed

Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles

Psoriasis | Dermatitis | Nevus

United States
National Cancer Institute (NCI)

Completed

Feasibility Study of Interleukin 1-Alpha With Ifosfamide, CBDCA, and Etoposide With Autologous Bone Marrow Transplant in Metastatic Carcinoma and Lymphoma

Lymphoma | Testicular Neoplasms | Breast Neoplasms | Neoplasm Metastasis

United States
National Institute of Diabetes and Digestive and...

Completed

Stem Cell (Modified Bone Marrow) Transplantation in HIV-Infected Patients With Blood Cancer

HIV Infection | Hematologic Neoplasm

United States
National Institute of Dental and Craniofacial Research...

Completed

Chemical and Genetic Effects of the Experimental Anti-Cancer Drugs in Cheek Cells in Cancer Patients

Cancer

United States
National Cancer Institute (NCI)

Completed

Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens

Alcoholism | HIV Infection | Kaposi's Sarcoma | Homosexuality

United States
National Cancer Institute (NCI)

Completed

Seroprevalence of Kaposi's Sarcoma Herpes Virus in the United States

Kaposi's Sarcoma | Herpesviridae Infection

United States
National Cancer Institute (NCI)

Completed

Chronic and Late Effects of Non-Hodgkin's Lymphoma and Its Treatment in Long Term Survivors

Lymphoma, Non-Hodgkin

United States
National Cancer Institute (NCI)

Completed

Genetic Component of Handedness

Healthy

United States

3

Subscribe